DMC Biotechnologies
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | $240k | Grant | |
$1.3m | Grant | ||
$1.2m | Seed | ||
$1.0m | Series A | ||
* | $34.0m | Series B | |
Total Funding | CAD51.5m |
Related Content
Recent News about DMC Biotechnologies
EditDMC Biotechnologies operates in the biomanufacturing sector, focusing on the sustainable and cost-effective production of bio-based chemicals. The company leverages its innovative technology and metabolic engineering expertise to rapidly commercialize a broad range of bio-based chemicals through precision fermentation. This process allows for the local production of materials using agricultural feedstocks, enabling customers to diversify their supply chains and increase resilience against global disruptions. DMC's business model revolves around collaborating with various industries to provide a reliable and economically sound supply of essential chemicals. The company generates revenue by offering its biomanufacturing services and products to clients in diverse markets, including agriculture, pharmaceuticals, and consumer goods. With a promising pipeline of products under development, DMC aims to revolutionize the chemical production industry by making it more sustainable and efficient.
Keywords: biomanufacturing, bio-based chemicals, precision fermentation, metabolic engineering, sustainable production, supply chain diversification, agricultural feedstocks, chemical production, innovation, resilience.